Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
TLPH Stock Forecast 2026-2027
$0.80
Current Price
$37.29M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to TLPH Price Targets
+337.5%
To High Target of $3.50
+306.2%
To Median Target of $3.25
+275.0%
To Low Target of $3.00
TLPH Price Momentum
-8.0%
1 Week Change
-1.2%
1 Month Change
+42.9%
1 Year Change
-29.8%
Year-to-Date Change
-49.0%
From 52W High of $1.57
+110.5%
From 52W Low of $0.38
📊 TOP ANALYST CALLS
Did TLPH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if AcelRx is one of their latest high-conviction picks.
Latest TLPH Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, TLPH has a bullish consensus with a median price target of $3.25 (ranging from $3.00 to $3.50). The overall analyst rating is N/A (N/A/10). Currently trading at $0.80, the median forecast implies a 306.2% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Jason McCarthy at Maxim Group, suggesting a 275.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
TLPH Analyst Ratings
2
Buy
0
Hold
0
Sell
TLPH Price Target Range
Low
$3.00
Average
$3.25
High
$3.50
Current: $0.80
Latest TLPH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for TLPH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 1, 2025 | HC Wainwright & Co. | Ed Arce | Buy | Reiterates | $6.00 |
| Jan 21, 2025 | HC Wainwright & Co. | Ed Arce | Buy | Reiterates | $6.00 |
| Aug 16, 2024 | HC Wainwright & Co. | Ed Arce | Buy | Reiterates | $6.00 |
| May 15, 2024 | HC Wainwright & Co. | Ed Arce | Buy | Reiterates | $6.00 |
| May 6, 2024 | Maxim Group | Jason McCarthy | Buy | Initiates | $3.00 |
| Mar 7, 2024 | HC Wainwright & Co. | Ed Arce | Buy | Reiterates | $6.00 |
| Jan 22, 2024 | HC Wainwright & Co. | Ed Arce | Buy | Maintains | $6.00 |
| Dec 7, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Oct 2, 2023 | Alliance Global Partners | Buy | Initiates | $N/A | |
| Sep 25, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 18, 2023 | HC Wainwright & Co. | Buy | Upgrade | $N/A |
Talphera Inc. (TLPH) Competitors
The following stocks are similar to AcelRx based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Talphera Inc. (TLPH) Financial Data
Talphera Inc. has a market capitalization of $37.29M with a P/E ratio of -1.6x. The company generates $28,000 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of -342,200.0% and return on equity of -86.5%.
Valuation Metrics
Market Cap
$37.29M
Enterprise Value
$22.97M
P/E Ratio
-1.6x
PEG Ratio
0.1x
Price/Sales
1,326.4x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
-342,200.0%
Net Margin
0.0%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+57.1%
Current Ratio
6.8x
Debt/Equity
33.9x
ROE
-86.5%
ROA
-31.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Talphera Inc. (TLPH) Business Model
About Talphera Inc.
What They Do
Provides renewable energy solutions through wind and solar.
Business Model
Talphera Inc. generates revenue by designing, developing, and deploying scalable wind and solar power technologies for both commercial and residential clients. The company focuses on energy efficiency innovations and storage solutions, which enhance its service offerings and attract a diverse customer base.
Additional Information
Talphera Inc. is recognized for its contributions to the global transition towards sustainable energy sources and is actively involved in modernizing energy infrastructure. Its commitment to reducing carbon footprints positions it as a key player in the renewable energy sector, aligning with growing market demands for green energy initiatives.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
13
CEO
Mr. Vincent J. Angotti
Country
United States
IPO Year
2011
Website
talphera.comTalphera Inc. (TLPH) Latest News & Analysis
Latest News
Quick Summary
Talphera, Inc. has enrolled 35 of 70 patients in its NEPHRO-CRRT clinical trial, reaching 50% enrollment. The company will host a virtual investor event on March 23 at 11:00 am ET.
Why It Matters
Talphera's 50% enrollment in a key clinical trial signals progress in drug development, potentially enhancing its valuation and market confidence, impacting stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Talphera, Inc. (TLPH) will hold its Q3 2025 earnings call on November 12, 2025, at 4:30 PM EST. The event will be available live on their website.
Why It Matters
Talphera's Q3 earnings call provides insights into financial performance and strategic direction, which could influence stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Talphera, Inc. closed a $17M financing led by CorMedix. Cash totaled $21.3M as of Sept 30, 2025. NEPHRO study completion expected in H1 2026, with PMA approval anticipated by late 2026.
Why It Matters
Talphera secured $17 million in financing, enhancing its cash position for upcoming PMA approval, crucial for product development. Active clinical sites boost the likelihood of positive study outcomes.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Talphera, Inc. (Nasdaq: TLPH) will release its Q3 2025 financial results on November 12, 2025, after market close, followed by a webcast and conference call at 4:30 p.m.
Why It Matters
Talphera's upcoming financial results release could impact its stock price, providing insights into its performance and growth potential, influencing investor sentiment and decisions.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Talphera, Inc. (Nasdaq: TLPH) appointed Joe Todisco, CEO of CorMedix Inc. (Nasdaq: CRMD), to its Board of Directors, enhancing its leadership in specialty pharmaceuticals.
Why It Matters
Talphera's board appointment of Joe Todisco may enhance strategic direction, potentially improving investor confidence and influencing stock performance positively.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
CorMedix Inc. has invested $5 million in Talphera, Inc., acquiring 9,090,909 shares at $0.55 each, as part of Talphera's private placement financing.
Why It Matters
CorMedix's $5 million investment in Talphera signals confidence in Talphera's potential, which may impact stock prices and investor sentiment for both companies.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About TLPH Stock
What is Talphera Inc.'s (TLPH) stock forecast for 2026?
Based on our analysis of 3 Wall Street analysts, Talphera Inc. (TLPH) has a median price target of $3.25. The highest price target is $3.50 and the lowest is $3.00.
Is TLPH stock a good investment in 2026?
According to current analyst ratings, TLPH has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.80. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for TLPH stock?
Wall Street analysts predict TLPH stock could reach $3.25 in the next 12 months. This represents a 306.2% increase from the current price of $0.80. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Talphera Inc.'s business model?
Talphera Inc. generates revenue by designing, developing, and deploying scalable wind and solar power technologies for both commercial and residential clients. The company focuses on energy efficiency innovations and storage solutions, which enhance its service offerings and attract a diverse customer base.
What is the highest forecasted price for TLPH Talphera Inc.?
The highest price target for TLPH is $3.50 from at , which represents a 337.5% increase from the current price of $0.80.
What is the lowest forecasted price for TLPH Talphera Inc.?
The lowest price target for TLPH is $3.00 from Jason McCarthy at Maxim Group, which represents a 275.0% increase from the current price of $0.80.
What is the overall TLPH consensus from analysts for Talphera Inc.?
The overall analyst consensus for TLPH is bullish. Out of 3 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $3.25.
How accurate are TLPH stock price projections?
Stock price projections, including those for Talphera Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: March 15, 2026 4:58 PM UTC